What is Sunrise ENT?
Sunrise ENT operates as a premier healthcare provider, maintaining a robust clinical network that spans New York, New Jersey, Pennsylvania, and Texas. By integrating ENT, allergy, and audiology services, the company has established a dominant market position, supported by a workforce of over 450 clinicians across 70 strategic locations. The organization distinguishes itself through a high-volume, patient-centric model, managing approximately 175,000 patient encounters monthly. This operational scale, combined with a focus on chronic condition management such as sinus issues and hearing loss, positions the firm as a critical infrastructure player in the regional healthcare landscape.
How much funding has Sunrise ENT raised?
Sunrise ENT has raised a total of $56K across 1 funding round:
Debt
$56K
Debt (2021): $56K with participation from PPP
Key Investors in Sunrise ENT
PPP
Public-Private Partnership
What's next for Sunrise ENT?
With the infusion of $56K, Sunrise ENT is poised to transition from its current growth phase into a period of aggressive market consolidation and technological integration. The strategic roadmap likely involves the expansion of its digital health capabilities to streamline the patient journey and the potential acquisition of smaller, regional practices to bolster its geographic reach. By leveraging its existing clinical density, the company aims to optimize administrative efficiencies and enhance the quality of care delivery, ensuring sustained competitive advantage in an increasingly fragmented specialty medicine market. Future initiatives will likely focus on scaling the audiology and allergy service lines to capture additional market share in its core territories.
See full Sunrise ENT company page
